Page last updated: 2024-10-24

carbamazepine and Leishmaniasis, Visceral

carbamazepine has been researched along with Leishmaniasis, Visceral in 1 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Van Horn, KS1
Zhu, X1
Pandharkar, T1
Yang, S1
Vesely, B1
Vanaerschot, M1
Dujardin, JC1
Rijal, S1
Kyle, DE1
Wang, MZ1
Werbovetz, KA1
Manetsch, R1

Other Studies

1 other study available for carbamazepine and Leishmaniasis, Visceral

ArticleYear
Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines.
    Journal of medicinal chemistry, 2014, Jun-26, Volume: 57, Issue:12

    Topics: Animals; Antimony; Cell Line; Diamines; Drug Resistance; Leishmania; Leishmania donovani; Leishmania

2014